Specialty · Infectious disease
Infectious disease research
Outbreak-response publishing demands its own playbook: rapid data deposit (GISAID, GenBank), tier-1 ISARIC standardised case-report forms, WHO R&D Blueprint pathways, preprint-first dissemination, and tightly-managed authorship patterns on large consortium papers. CASRAI vocabulary anchors the language so urgent collaborations don't fragment into incompatible records.
Layered onto general standards
Infectious-disease-specific conventions
GISAID
Global Initiative on Sharing All Influenza Data — now covers SARS-CoV-2, mpox, H5N1; mandatory data-access agreement.
GenBank / ENA / DDBJ
International Nucleotide Sequence Database Collaboration — sequence deposit for any infectious-disease study.
ISARIC tier-1 CRFs
Standardised case-report forms used during COVID-19 and earlier outbreaks; permit multi-site data pooling.
WHO R&D Blueprint
Priority pathogen list + research roadmaps; shapes funder + publisher response cadence.
MIxS (Genomic Standards Consortium)
Minimum Information about any Sequence — structured metadata standard for sequence data.
CONSORT extensions for vaccine trials
CONSORT-PRO and the AdditionalIM extensions relevant for vaccine RCTs.
Preprint-first norms
bioRxiv / medRxiv preprint deposit ahead of peer review during outbreaks — encouraged by most journals and the WHO.
